Trial Profile
A Prospective Phase II Study of Bendamustine in Patients Aged Over 60 Years With Classical Hodgkin Lymphoma Treated by Prednisone, Vinblastine and Doxorubicin
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 23 Nov 2023
Price :
$35
*
At a glance
- Drugs Bendamustine (Primary) ; Doxorubicin; Prednisone; Vinblastine
- Indications Hodgkin's disease
- Focus Therapeutic Use
- Acronyms LYSA
- 18 Nov 2023 Results published in the Blood.
- 14 Dec 2021 Final Results presented at the 63rd American Society of Hematology Annual Meeting and Exposition
- 18 Feb 2021 Status changed from active, no longer recruiting to completed.